Algorae Pharmaceuticals【1AI】銘柄情報

Algorae Pharmaceuticals Limited (1AI) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.012

( - )

買値

0.011

売値

0.012

出来高

0.00

0.00 日の範囲 0.00

0.005 52 週間の範囲 0.024

時価総額

24.277M

前日終値

0.012

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 1,731,705

発行済株式数

2,023,070,155

配当利回り

PER

-19.17

1 株当たり利益 (EPS)

-0

歳入

純利益

-1.01M

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatm... Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate coated capsule product for the treatment of Parkinson’s disease. It is also developing AlgaraeOS in partnership with the University of New South Wales, a drug discovery platform that uses artificial intelligence protocols and big data analytics for drug discovery and development. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

algoraepharma.com

本社

Melbourne, Australia

設立

1987

Algorae Pharmaceuticals Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker 1AI. The last closing price for Algorae Pharmaceuticals was AUD0.01. Over the last year, Algorae Pharmaceuticals shares have traded in a share price range of AUD 0.005 to AUD 0.024.

Algorae Pharmaceuticals currently has 2,023,070,155 shares in issue. The market capitalisation of Algorae Pharmaceuticals is AUD24.28 million. Algorae Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.17.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.012	0.012	0.011	113984	0.01137335	DE
4	-0.002	-14.2857142857	0.014	0.014	0.011	774138	0.01320675	DE
12	-0.001	-7.69230769231	0.013	0.018	0.011	1640404	0.01370413	DE
26	-0.002	-14.2857142857	0.014	0.024	0.011	1725712	0.01570881	DE
52	0.007	140	0.005	0.024	0.005	1758732	0.01239446	DE
156	-0.003	-20	0.015	0.024	0.005	1456472	0.01074326	DE
260	-0.003	-20	0.015	0.024	0.005	1456472	0.01074326	DE